Panzyga in CIDP Administered at Different Infusion Rates

Clinical trial NCT03166527 · UNKNOWN

Trial details

NCT number: NCT03166527
Sponsor: Vera Bril
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Start date: 2017-06-01
Primary completion: 2018-12-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.